Hepatoid Adenocarcinoma-Clinicopathological Features and Molecular Characteristics
Overview
Affiliations
Hepatoid adenocarcinoma (HAC) is a rare, malignant, extrahepatic tumor with histologic features similar to those of hepatocellular carcinoma. HAC is most often associated with elevated alpha-fetoprotein (AFP). HAC can occur in multiple organs, including the stomach, esophagus, colon, pancreas, lungs, and ovaries. HAC differs greatly from typical adenocarcinoma in terms of its biological aggression, poor prognosis, and clinicopathological characteristics. However, the mechanisms underlying its development and invasive metastasis remain unclear. The purpose of this review was to summarize the clinicopathological features, molecular traits, and molecular mechanisms driving the malignant phenotype of HAC, in order to support the clinical diagnosis and treatment of HAC.
Lu G, Tu J, Tu J, Jiang R Front Immunol. 2025; 16:1513604.
PMID: 39931054 PMC: 11808132. DOI: 10.3389/fimmu.2025.1513604.
Gu X, Rong J, Zhu L, Dai Z, Ren S, Chen J J Gastrointest Oncol. 2024; 15(5):2041-2052.
PMID: 39554578 PMC: 11565099. DOI: 10.21037/jgo-24-210.
Taniguchi Y, Kiyozawa D, Kohashi K, Kawatoko S, Yamamoto T, Torisu T Gastric Cancer. 2024; 28(1):41-50.
PMID: 39488822 PMC: 11706836. DOI: 10.1007/s10120-024-01562-x.
A case study of unexplained multiple hepatoid adenocarcinoma of the bone.
Xie Q, Wang L, Cheng J, Chen W, Cai P, Zhang H Quant Imaging Med Surg. 2024; 14(9):7018-7023.
PMID: 39281113 PMC: 11400692. DOI: 10.21037/qims-24-321.
Deng H, Wang L, Li Z, Zhan T, Huang L BMC Cancer. 2024; 24(1):948.
PMID: 39095810 PMC: 11297620. DOI: 10.1186/s12885-024-12682-z.